Actionnariat et activité des initiés pour Ensysce Biosciences, Inc. (ENSC): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.45 |
| Capitalisation | $7M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-07 | GOWER BOB G | P-Purchase | 400,000 | $198K |
| 2026-04-23 | GOWER BOB G | P-Purchase | 508,614 | $246K |
| 2026-04-23 | GOWER BOB G | C-Conversion | 254,307 | $123K |
| 2026-08-05 | Morrison James William | 154,821,000 | ||
| 2023-03-02 | GOWER BOB G | P-Purchase | 90,287 | $44K |
| 2023-03-01 | GOWER BOB G | P-Purchase | 270,000 | $129K |
| 2023-02-28 | GOWER BOB G | P-Purchase | 109,300 | $53K |
| 2022-12-09 | GOWER BOB G | P-Purchase | 357,143 | $500K |
| 2022-12-09 | GOWER BOB G | A-Award | 714,286 | $1.0M |
| 2022-06-23 | Chang William H | A-Award | 15,000 |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $2.1M | $1.7M | $341536 | $194214 | $12.3M | $3.1M | $1.1M | $3.5M | $4.3M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | 0 | $170535 | $173552 | 0 | $441721 | $276821 | $97561 | $124115 | $420345 |
| Stocks | 0 | 0 | 0 | 0 | -$441721 | 0 | 0 | 0 | 0 |
| Actifs Courants | $2.3M | $1.9M | $618590 | $347876 | $15.7M | $5.3M | $2.3M | $5.3M | $7.2M |
| Immobilisations Corporelles | 0 | 0 | $351 | $151 | $24.72B | 0 | 0 | 0 | $124129 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $202.4M | $204.8M | $623941 | $351807 | $16.4M | $5.9M | $2.7M | $5.6M | $7.5M |
| Dettes Fournisseurs | 0 | 0 | $540778 | $1.7M | $301104 | $2.9M | $1.9M | $1.4M | $3.3M |
| Dette à Court Terme | 0 | 0 | $2.6M | $4.2M | $12.7M | $4.3M | $854697 | $301660 | $306708 |
| Passifs Courants | $156239 | $437886 | $7.3M | $7.0M | $16.5M | $9.5M | $3.3M | $2.2M | $4.6M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | $4.4M | $140148 | 0 | 0 | 0 |
| Passifs Totaux | $7.2M | $7.4M | $7.3M | $7.0M | $24.6M | $9.9M | $3.4M | $2.2M | $4.6M |
| Réserves | -$31193 | $2.1M | -$56.0M | -$56.0M | -$85.8M | -$110.9M | -$121.6M | -$129.5M | -$139.7M |
| Capitaux Propres | $195.3M | $197.4M | -$6.7M | -$6.4M | -$7.9M | -$3.7M | -$322858 | $3.7M | $3.2M |
| Dette Totale | 0 | 0 | $2.6M | $4.3M | $17.2M | $4.4M | $854697 | $301660 | $306708 |
| Dette Nette | -$2.1M | -$1.7M | $2.3M | $4.1M | $4.9M | $1.3M | -$268907 | -$3.2M | -$4.0M |
| Fonds de Roulement | $2.2M | $1.5M | -$6.7M | -$6.7M | -$819073 | -$4.2M | -$1.0M | $3.1M | $2.7M |
Santé financière
| Dette / Capitaux propres | -0.25 |
| Ratio de liquidité | 0.70 |
| Piotroski F-Score | 0 |
| Altman Z-Score | -29.36 |
Rentabilité
| Rentabilité des capitaux propres | -316.63% |
| Rentabilité du capital investi | -320.89% |
| Rentabilité des actifs | -136.54% |
| Marge brute | 100.00% |
| Marge opérationnelle | -1087.47% |
| Marge nette | -1084.23% |
Entreprises liées: AIM · CANF · KALA · KZIA · OGEN · QLGN · SNGX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ENSC: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions